Patent 12060583 was granted and assigned to Merck Sharp & Dohme Limited on August, 2024 by the United States Patent and Trademark Office.
The present invention relates to a scalable process for the purification of human cytomegalovirus particles from cell culture medium. In particular, the process involves a two step chromatography process starting with an anion exchange chromatography step followed by a polishing chromatography step selected from mixed mode chromatography or cation exchange chromatography.